| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0179 | 2,4-bis(p-hydroxyphenyl)-2-butenal | Concentration- and time-dependent inhibitor of the growth of NSCLC cells inducing apoptosis |
|
| DCC0180 | 2,4-dichloroamphetamine Hcl | Stimulator of the central nervous system, decreasing the 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels in brain |
|
| DCC0181 | 2,5-2f-kbz | Novel Versatile Probe for Interrogating Histone Benzoylation and Interactions in Living Cells |
|
| DCC0182 | 24(s),25-epoxycholesterol | Oxysterol agonist of the liver X receptor |
|
| DCC0183 | 24(s)-saringosterol | Novel Selective LXRβ Agonist |
|
| DCC0184 | 27-caua | Novel selective inhibitor of EGFR kinase, leading to inactivation of PI3K/AKT/mTOR and Ras-Raf-MEK-ERK signal pathways |
|
| DCC0185 | 2-ampp | Novel GPR88 Agonist |
|
| DCC0186 | 2b182c | Novel potent activator of both human and mouse TLR4-NF-κB reporter cells and primary cells, inducing serum anti-HA and anti-NA IgG1 levels |
|
| DCC0187 | 2-bispeb | Metabotropic Glutamate Receptor 5-selective Negative Allosteric Modulator |
|
| DCC0188 | 2ccpa Sodium | Lipid mediator, regulates neuronal apoptosis in traumatic brain injury (TBI) |
|
| DCC0189 | 2-cl-8-ma-camp | Site BI- selective synergistic activator of PKA I |
|
| DCC0190 | 2-cldg | Inhibitor of cellular glycosylation; Analytical standard |
|
| DCC0191 | 2'-deoxy-adpr | Endogenous superagonist of transient receptor potential melastatin 2 (TRPM2) |
|
| DCC0192 | 2-ethoxystypandrone | Novel potent natural STAT3 signaling inhibitor from Polygonum cuspidatum, inhibiting cell growth and inducing apoptosis of HCC cells and HCC Cancer stem cells. |
|
| DCC0193 | 2-furoyl-ligrlo-amide | Potent and selective PAR2 receptor agonist |
|
| DCC0194 | 2-hexylthio-β,γ-ch2-atp | Non-hydrolyzable ATP analog, acting as an effective and selective NTPDase2 inhibitor |
|
| DCC0195 | 2-hydroxyethyl-sp600125 | Potent and selective JNK inhibitor; Analogue of SP600125 with improved potency and selectivity |
|
| DCC0196 | 2-iodoestradiol | Potent human sex hormone binding globulin (SHBG) ligand |
|
| DCC0197 | 2-mc-1,4-nhq | Inhibitor of the Cdc42-PBD interaction, blocking the association of Cdc42 with the PBD |
|
| DCC0198 | 2-o-acetylcorosolic Acid | Antiatherosclerotic, antihyperlipidemic, antiinflammatory, antifungal, antiviral and antineoplastic |
|
| DCC0199 | 2-oh-5-f-dppro | Novel inhibitor of thioredoxin reductase (TrxR) |
|
| DCC0200 | 2-oxaadamantane 22 | Novel inhibitor of soluble epoxide hydrolase (sEH), showing good solubility, microsomal stability, and selectivity for sEH |
|
| DCC0201 | 2ppg-fk-acrha | Novel double photocaged cathepsin B activity-based probe for monitoring the light-activation by the blue fluorescence of 7-diethylamino-4-hydroxymethyl-coumarin (DEACM) and simultaneously probe the activity of cathepsin B through the green fluorescence of |
|
| DCC0202 | 2r,4r-apdc | Highly selective and relatively potent group II metabotropic glutamate receptor agonist |
|
| DCC0203 | 3,3',4,4',5,5'-hms | Novel pro-angiogenic agent, potently promoting proliferation, migration, invasion and tube formation of human umbilical vein VECs (HUVECs) in vitro |
|
| DCC0204 | 3,3'-biplumbagin | Novel, active, and less toxic anti-tuberculosis (anti-TB) agent |
|
| DCC0205 | 3',3'-c-di(2'f,2'damp) | Novel STING Agonist |
|
| DCC0206 | 3,4,5-tri-cqa | Inhibitor of Beta_amyloid>amyloid β-mediated cellular toxicity |
|
| DCC0207 | 3,4-dcqame | Natural inhibitor of respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane. |
|
| DCC0208 | 3,4-di-o-acetyl-l-rhamnal | Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1) |
|
